Mepolizumab Beat Omalizumab on Asthma Attacks in Real-World Head-to-Head Cohort
A retrospective cohort study of 49 severe asthma patients eligible for both biologics found mepolizumab cut clinically significant exacerbations by ...
A retrospective cohort study of 49 severe asthma patients eligible for both biologics found mepolizumab cut clinically significant exacerbations by ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.